HBIO Share Price |
||||
| Open | 2.80 | Change | Price | % |
| High | 2.95 | 1 Day | -0.08 | -2.88 |
| Low | 2.65 | 1 Week | -0.30 | -10.00 |
| Close | 2.70 | 1 Month | 0.20 | 8.00 |
| Volume | 51604 | 1 Year | 0.03 | 1.12 |
| 52 Week High 3.30 | ||||
| 52 Week Low 2.25 | ||||
| HBIO Important Levels | |
| Resistance 2 | 2.98 |
| Resistance 1 | 2.86 |
| Pivot | 2.77 |
| Support 1 | 2.54 |
| Support 2 | 2.42 |
| NASDAQ USA Most Active Stocks | |||
| YHOO | 52.58 | 0.00% | |
| YHOO | 52.58 | 0.00% | |
| YHOO | 52.58 | 0.00% | |
| FNFG | 10.18 | -0.20% | |
| DELL | 13.86 | 0.22% | |
| RFMD | 16.59 | -2.07% | |
| RIMM | 13.03 | 0.39% | |
| BBEP | 0.12 | 0.00% | |
| GTAT | 0.44 | 0.00% | |
| SUSQ | 14.20 | -0.77% | |
| NASDAQ USA Top Gainers Stocks | |||
| AMCF | 0.03 | 50.00% | |
| LOCM | 0.09 | 50.00% | |
| ATEA | 2.50 | 32.98% | |
| ATEA | 2.50 | 32.98% | |
| BSDM | 0.62 | 26.53% | |
| SNTA | 0.34 | 25.93% | |
| OTT | 2.39 | 25.13% | |
| BGMD | 0.05 | 25.00% | |
| ATRM | 1.70 | 21.43% | |
| MIND | 3.33 | 15.62% | |
| NASDAQ USA Top Losers Stocks | |||
| TXCC | 0.01 | -95.00% | |
| HCIIP | 10.10 | -67.52% | |
| CRMB | 0.27 | -57.81% | |
| KIOR | 0.03 | -57.14% | |
| OSH | 0.26 | -49.02% | |
| OSH | 0.26 | -49.02% | |
| DVOX | 0.05 | -44.44% | |
| PRXI | 0.21 | -43.24% | |
| TRGT | 0.96 | -41.46% | |
| DCIX | 0.26 | -40.91% | |
Harvard Bioscience, Inc. (NASDAQ: HBIO)
| HBIO Technical Analysis | 3 |
| As on 23rd Aug 2017 HBIO Share Price closed @ 2.70 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2.65 & Buy for SHORT-TERM with Stoploss of 2.69 we also expect STOCK to react on Following IMPORTANT LEVELS. | |
| HBIO Target for August | |
| 1st Target up-side | 3.07 |
| 2nd Target up-side | 3.26 |
| 3rd Target up-side | 3.45 |
| 1st Target down-side | 2.53 |
| 2nd Target down-side | 2.34 |
| 3rd Target down-side | 2.15 |
Harvard Bioscience, Inc. ( NASDAQ USA Symbol : HBIO ) Sector : Healthcare And Other Stocks in Same Sector |
|||||
|
ABAX
46.17 -0.91 (-1.93 %) LT : Strong Sell ST : Strong Sell |
ABIO
1.10 0.05 (4.76 %) LT : Strong Sell ST : Strong Sell |
ABMD
152.90 -2.09 (-1.35 %) LT : Strong Buy ST : Strong Buy |
ACAD
31.91 0.47 (1.49 %) LT : Buy ST : Strong Buy |
ACHC
47.43 -0.19 (-0.40 %) LT : Buy ST : Sell |
|
|
|
||||||||||||||||||||||
|
Interactive Technical Analysis Chart Harvard Bioscience, Inc. ( HBIO NASDAQ USA )
Your Comments and Response on Harvard Bioscience, Inc.
HBIO Business Profile
Harvard Bioscience, Inc. is a global developer, manufacturer and marketer of a range of specialized products, apparatus and scientific instruments, used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. The Company sells its products to thousands of researchers in over 100 countries through its 850 page catalog (and various other specialty catalogs), Website, through distributors, including GE Healthcare, Thermo Fisher Scientific Inc. and VWR, and via its field sales organization. The Company�s product range is targeted towards two application areas: ADMET testing and molecular biology. In October 2013, the Company announced the spin-off of its wholly owned regenerative medicine device subsidiary, Harvard Apparatus Regenerative Technology, Inc.